HUP0003629A3 - Synergic pharmaceutical composition for the treatment of diabetes containing thiazolidinedione, insulin secretagogue and diguanide - Google Patents

Synergic pharmaceutical composition for the treatment of diabetes containing thiazolidinedione, insulin secretagogue and diguanide

Info

Publication number
HUP0003629A3
HUP0003629A3 HU0003629A HUP0003629A HUP0003629A3 HU P0003629 A3 HUP0003629 A3 HU P0003629A3 HU 0003629 A HU0003629 A HU 0003629A HU P0003629 A HUP0003629 A HU P0003629A HU P0003629 A3 HUP0003629 A3 HU P0003629A3
Authority
HU
Hungary
Prior art keywords
diguanide
treatment
pharmaceutical composition
insulin secretagogue
diabetes containing
Prior art date
Application number
HU0003629A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of HUP0003629A2 publication Critical patent/HUP0003629A2/hu
Publication of HUP0003629A3 publication Critical patent/HUP0003629A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HU0003629A 1997-07-18 1998-07-16 Synergic pharmaceutical composition for the treatment of diabetes containing thiazolidinedione, insulin secretagogue and diguanide HUP0003629A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9715295A GB9715295D0 (en) 1997-07-18 1997-07-18 Novel method of treatment
PCT/GB1998/002110 WO1999003477A1 (en) 1997-07-18 1998-07-16 Treatment of diabetes with thiazolidinedione, insulin secretagogue and diguanide

Publications (2)

Publication Number Publication Date
HUP0003629A2 HUP0003629A2 (hu) 2001-07-30
HUP0003629A3 true HUP0003629A3 (en) 2003-04-28

Family

ID=10816167

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0003629A HUP0003629A3 (en) 1997-07-18 1998-07-16 Synergic pharmaceutical composition for the treatment of diabetes containing thiazolidinedione, insulin secretagogue and diguanide

Country Status (39)

Country Link
EP (1) EP1001783B1 (cg-RX-API-DMAC10.html)
JP (2) JP2001510159A (cg-RX-API-DMAC10.html)
KR (1) KR100671918B1 (cg-RX-API-DMAC10.html)
CN (1) CN1264303A (cg-RX-API-DMAC10.html)
AP (1) AP1352A (cg-RX-API-DMAC10.html)
AR (1) AR016349A1 (cg-RX-API-DMAC10.html)
AT (1) ATE305790T1 (cg-RX-API-DMAC10.html)
AU (1) AU8448898A (cg-RX-API-DMAC10.html)
BG (1) BG64785B1 (cg-RX-API-DMAC10.html)
BR (1) BR9810445A (cg-RX-API-DMAC10.html)
CA (1) CA2296653C (cg-RX-API-DMAC10.html)
CO (1) CO4940420A1 (cg-RX-API-DMAC10.html)
CY (1) CY1105254T1 (cg-RX-API-DMAC10.html)
DE (1) DE69831808T2 (cg-RX-API-DMAC10.html)
DK (1) DK1001783T3 (cg-RX-API-DMAC10.html)
DZ (1) DZ2562A1 (cg-RX-API-DMAC10.html)
EA (1) EA003021B1 (cg-RX-API-DMAC10.html)
ES (1) ES2251093T3 (cg-RX-API-DMAC10.html)
GB (1) GB9715295D0 (cg-RX-API-DMAC10.html)
HU (1) HUP0003629A3 (cg-RX-API-DMAC10.html)
ID (1) ID24211A (cg-RX-API-DMAC10.html)
IL (1) IL134046A0 (cg-RX-API-DMAC10.html)
IN (1) IN189275B (cg-RX-API-DMAC10.html)
MA (1) MA24607A1 (cg-RX-API-DMAC10.html)
MY (1) MY155219A (cg-RX-API-DMAC10.html)
NO (1) NO325727B1 (cg-RX-API-DMAC10.html)
NZ (2) NZ511608A (cg-RX-API-DMAC10.html)
OA (1) OA11279A (cg-RX-API-DMAC10.html)
PE (1) PE99599A1 (cg-RX-API-DMAC10.html)
PL (2) PL198017B1 (cg-RX-API-DMAC10.html)
SA (1) SA98190468B1 (cg-RX-API-DMAC10.html)
SI (1) SI1001783T1 (cg-RX-API-DMAC10.html)
SK (1) SK285484B6 (cg-RX-API-DMAC10.html)
TR (1) TR200000134T2 (cg-RX-API-DMAC10.html)
TW (1) TW505516B (cg-RX-API-DMAC10.html)
UA (1) UA70303C2 (cg-RX-API-DMAC10.html)
UY (1) UY25102A1 (cg-RX-API-DMAC10.html)
WO (1) WO1999003477A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA986363B (cg-RX-API-DMAC10.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6011049A (en) * 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
DE69939485D1 (de) * 1998-11-12 2008-10-16 Smithkline Beecham Plc Arzneimittel zur gesteuerten freisetzung eines insulin sensibilisators und metformin
SE9902918D0 (sv) * 1999-08-13 1999-08-13 Pharmacia & Upjohn Ab Methods for identification of compounds stimulating insulin secretion
AR030920A1 (es) * 1999-11-16 2003-09-03 Smithkline Beecham Plc Composiciones farmaceuticas para el tratamiento de la diabetes mellitus y condiciones asociadas con la diabetes mellitus, y procedimientos para preparar dichas composiciones
WO2001035940A2 (en) * 1999-11-16 2001-05-25 Smithkline Beecham P.L.C. Pharmaceutical composition comprising a thiazolidinedione-metformin hydrochloride
FR2812547B1 (fr) * 2000-08-04 2002-10-31 Lipha Composition pharmaceutique comprenant une association metformine et derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete
JP4633329B2 (ja) 2001-01-12 2011-02-16 サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド スペーストドラッグデリバリーシステム
ITFI20010126A1 (it) * 2001-07-09 2003-01-09 Molteni & C Composizioni farmaceutiche per uso orale,contenenti,in combinazione,metformina e gliclazide
WO2003005995A1 (en) * 2001-07-10 2003-01-23 Aeropharm Technology Incorporated Core formulation comprising pioglitazone hydrochloride and a biguanide
AU2002356419A1 (en) 2002-06-17 2003-12-31 Themis Laboratories Private Limited Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
CN100544717C (zh) * 2002-09-20 2009-09-30 华生制药公司 含有双胍和噻唑烷二酮衍生物的药物剂型
UA80991C2 (en) 2002-10-07 2007-11-26 Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes
BRPI0414979A (pt) 2003-10-31 2006-11-21 Takeda Pharmaceutical preparação sólida
MXPA05010977A (es) * 2005-10-12 2007-04-11 Abdala Leopoldo Espinosa Composiciones farmaceuticas que comprenden sustancias antidiabeticas combinadas para su uso en diabetes mellitus.
KR100812538B1 (ko) * 2006-10-23 2008-03-11 한올제약주식회사 약물 제어방출형 메트포르민-글리메피리드 복합제제
CN101417130B (zh) * 2007-10-22 2010-10-06 鲁南制药集团股份有限公司 一种治疗ⅱ型糖尿病及其并发症的药物组合物
JP7005050B2 (ja) * 2017-10-20 2022-01-21 ノブメタファーマ カンパニー リミテッド 亜鉛塩、シクロ－ヒスプロおよび抗糖尿薬物を有効成分として含有する糖尿病の予防または治療用薬学的組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
JPS5697277A (en) * 1980-01-07 1981-08-05 Takeda Chem Ind Ltd Thiazolidine derivative
JPS6051189A (ja) * 1983-08-30 1985-03-22 Sankyo Co Ltd チアゾリジン誘導体およびその製造法
US4582839A (en) * 1984-03-21 1986-04-15 Takeda Chemical Industries, Ltd. 2,4-thiazolidinediones
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物，其制备方法和用途
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
US4812570A (en) * 1986-07-24 1989-03-14 Takeda Chemical Industries, Ltd. Method for producing thiazolidinedione derivatives
US4791125A (en) * 1987-12-02 1988-12-13 Pfizer Inc. Thiazolidinediones as hypoglycemic and anti-atherosclerosis agents
MX15171A (es) * 1988-03-08 1993-05-01 Pfizer Derivados de tiazolidinodiona hipoglicemicos
US5061717A (en) * 1988-03-08 1991-10-29 Pfizer Inc. Thiazolidinedione hypoglycemic agents
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
JPH04210683A (ja) * 1990-12-06 1992-07-31 Terumo Corp チアゾリジン−２，４−ジオン誘導体およびこれを含有する糖尿病合併症治療薬
DE69219136T2 (de) * 1991-08-26 1997-08-28 Pharmacia & Upjohn Co., Kalamazoo, Mich. Flüssiges nahrungsmittel, das 3-guanidinopropionsäure enthält
US5917052A (en) * 1994-09-28 1999-06-29 Shaman Pharmaceuticals, Inc. Hypoglycemic agent from cryptolepis
TW438587B (en) * 1995-06-20 2001-06-07 Takeda Chemical Industries Ltd A pharmaceutical composition for prophylaxis and treatment of diabetes
CA2294385C (en) * 1997-06-18 2007-06-05 Smithkline Beecham P.L.C. Treatment of diabetes with thiazolidinedione and sulphonylurea

Also Published As

Publication number Publication date
CN1264303A (zh) 2000-08-23
PL197844B1 (pl) 2008-05-30
SI1001783T1 (sl) 2006-02-28
ZA986363B (en) 2000-01-17
AP2000001733A0 (en) 2000-03-31
JP2005213273A (ja) 2005-08-11
CA2296653A1 (en) 1999-01-28
IN189275B (cg-RX-API-DMAC10.html) 2003-01-25
NZ501164A (en) 2001-06-29
TR200000134T2 (tr) 2000-09-21
KR100671918B1 (ko) 2007-01-22
JP2001510159A (ja) 2001-07-31
PL338126A1 (en) 2000-09-25
ATE305790T1 (de) 2005-10-15
SA98190468B1 (ar) 2007-01-20
HK1028550A1 (en) 2001-02-23
ID24211A (id) 2000-07-13
NO20000228D0 (no) 2000-01-17
BG64785B1 (bg) 2006-04-28
NO20000228L (no) 2000-01-17
NZ511608A (en) 2002-12-20
NO325727B1 (no) 2008-07-07
IL134046A0 (en) 2001-04-30
SK592000A3 (en) 2000-09-12
AU8448898A (en) 1999-02-10
HUP0003629A2 (hu) 2001-07-30
BG104135A (en) 2000-10-31
ES2251093T3 (es) 2006-04-16
CO4940420A1 (es) 2000-07-24
DK1001783T3 (da) 2006-02-06
AP1352A (en) 2004-12-24
AR016349A1 (es) 2001-07-04
CY1105254T1 (el) 2010-03-03
EP1001783B1 (en) 2005-10-05
UA70303C2 (uk) 2004-10-15
KR20010021947A (ko) 2001-03-15
GB9715295D0 (en) 1997-09-24
TW505516B (en) 2002-10-11
EP1001783A1 (en) 2000-05-24
PL198017B1 (pl) 2008-05-30
MA24607A1 (fr) 1999-04-01
DE69831808D1 (de) 2006-02-16
DZ2562A1 (fr) 2003-02-15
EA200000139A1 (ru) 2000-06-26
EA003021B1 (ru) 2002-12-26
PE99599A1 (es) 1999-12-18
MY155219A (en) 2015-09-30
BR9810445A (pt) 2000-09-05
UY25102A1 (es) 2000-12-29
SK285484B6 (sk) 2007-02-01
WO1999003477A1 (en) 1999-01-28
DE69831808T2 (de) 2006-07-06
CA2296653C (en) 2007-10-02
OA11279A (en) 2003-07-31

Similar Documents

Publication Publication Date Title
HUP0003629A3 (en) Synergic pharmaceutical composition for the treatment of diabetes containing thiazolidinedione, insulin secretagogue and diguanide
ZA975866B (en) Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases.
HUP0200556A3 (en) Medicament for treating diabetes
NL300432I2 (en) Pharmaceutical composition comprising pioglitazoneand glimepiride for use in treatment of diabetes.
AP9901719A0 (en) Treatment of diabetes with thiazolidinedione and metormin
IL144730A (en) Use of statin drug in the preparation of a medicament and as a medicament for the treatment of diabetic neuropathy
HUP0200831A3 (en) Novel pharmaceutical composition containing amoxycillin and its use
IL147217A0 (en) New spirooxindole derivatives and pharmaceutical compositions containing the same for treatment of pain
IL127219A0 (en) The use of insulin sensitivity enhancers for treatment of hyperuricemia and compositions containing insulin sensitivity enhancers for treating the same
HUP0100391A3 (en) Monomeric insulin analogs and their use pharmaceutical composition containing
IL130784A0 (en) Use of an anti-cd40l compound in the manufacture of a medicament for treating a patient with immune complex disease and pharmaceutical compositions containing the same
IL127572A (en) Pharmaceutical composition and medicament for nasal administration
IL125820A0 (en) Therapeutic agent for diabetes and a pharmaceutical composition containing the same
HUP0102292A3 (en) Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use
HUP0003260A3 (en) Pharmaceutical composition for treatment of diabetes with rosiglitazone and insulin
HUP0003626A3 (en) Pharmaceutical composition for treatment of diabetes with thiazolidinedione, insulin secretagogue and alpha glucocidase inhibitor
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
HUP0004410A3 (en) A one dose syringe, comprising a freeze-dried protein composition, for administering of a volume less than 0,5ml
HUP0003634A3 (en) Use of thiazolidinedione and sulphonylurea derivatives for the preparation of pharmaceutical compositions treating diabetes
AP9901717A0 (en) Treatment of diabetes with thiazolidinedione and sulphonylurea
IL99666A0 (en) Pharmaceutical compositions for the treatment of diabetes
HUP0203285A3 (en) Pharmaceutical composition comprising an insulin sensitizer and its use
HUP0301137A3 (en) Thiazolidinedione salt for treatment of diabetes mellitus, process for its preparation and pharmaceutical composition containing the same
DE69811253D1 (de) Osteoblastenspezifische mitogene und diese verbindungen enthaltende arzneimittel
HUP0104623A3 (en) Cyclosporin solution, pharmaceutical composition comprising thereof and its use

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished